This pharma company trades higher after receiving final approval from US FDA for its new drug application This pharma company trades higher after receiving final approval from US FDA for its new drug application Shares of the company zoomed 8 per cent on getting the final nod for Ketorolac Tromethamine Injection. Vishwesh Sanas / Thursday, November 3, 2022 / Article rating: 4.1 Shares of the company zoomed 8 per cent on getting the final nod for Ketorolac Tromethamine Injection.